Inflammatory biomarker may indicate coronary lesion

08/19/2013 | MedPage Today (free registration)

A study that used intravascular ultrasound and optical coherence tomography found the biomarker pentraxin 3 could serve as a red flag that patients are at risk of heart attack, researchers argue in JACC: Cardiovascular Interventions. Also in this article, using carotid intima-media thickness to determine vascular age and combining it with the Framingham risk score could help identify patients at risk of a severe heart attack, according to a report published in the journal Echocardiography.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN